Vanguard Personalized Indexing Management, LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Vanguard Personalized Indexing Management, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$205,547
-7.0%
3,946
+13.0%
0.01%
-14.3%
Q2 2023$221,0503,4910.01%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2023
NameSharesValueWeighting ↓
DCF Advisers, LLC 424,500$13,499,0005.57%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$6,360,0003.70%
Asymmetry Capital Management, L.P. 130,654$4,155,0001.90%
Altium Capital Management LP 153,348$4,876,0001.82%
Sofinnova Investments, Inc. 848,162$26,972,0001.61%
Bellevue Group AG 3,659,919$116,386,0001.33%
Eversept Partners, LP 356,235$11,328,2731.33%
Rhenman & Partners Asset Management AB 500,000$15,900,0001.30%
GENERAL AMERICAN INVESTORS CO INC 347,497$11,050,0001.09%
WASATCH ADVISORS LP 6,333,900$201,418,0000.99%
View complete list of INTRA CELLULAR THERAPIES INC shareholders